Drug Type Biosimilar, Monoclonal antibody |
Synonyms- |
Target |
Mechanism IL-12 inhibitors(Interleukin-12 inhibitors), IL-23 inhibitors(Interleukin-23 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (25 Sep 2023), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Arthritis, Psoriatic | JP | 25 Sep 2023 | |
Plaque psoriasis | JP | 25 Sep 2023 |